For at mindske risikoen for infektion med Neisseria meningitidis skal alle patienter vaccineres mindst 2 uger, før de får Soliris, og skal revaccineres efter de gældende retningslinjer for vaccination (se pkt.
To reduce the risk of meningococcal infection (Neisseria meningitidis), all patients must be vaccinated at least 2 weeks prior to receiving Soliris and must be re-vaccinated according to current medical guidelines for vaccination use (see section 4.4).